跳至主要内容
临床试验/NCT06934824
NCT06934824尚未招募不适用

Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1b

Hebei Medical University0 个研究点目标入组 60 人开始时间: 2025年5月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
主要终点
Rate of recurrence

研究概览

简要总结

For patients diagnosed with early gastric cancer involving submucosal invasion, super-ESD indications, or lymph node metastasis, a combination of preoperative endoscopic ultrasound and abdominal contrast-enhanced CT was utilized to ascertain the depth of tumor invasion and to identify any suspicious metastatic lymph nodes in the vicinity of the stomach. Subsequently, a local full-thickness resection, coupled with or followed by individualized precise lymph node dissection, was conducted to fulfill the following objectives: ① To investigate the safety, feasibility, and efficacy of local resection for patients meeting super-ESD criteria; ② To offer a clinical foundation for the individualized and precise lymph node dissection treatment of early gastric cancer.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-70 years old;
  • Endoscopic pathological diagnosis: adenocarcinoma;
  • Enhanced abdominal CT combined with endoscopic ultrasound clinical staging: T1bN0-1M
  • Has not received other treatment;
  • No other serious comorbidities;
  • Agree to participate in the study and sign the informed consent form.

排除标准

  • Pregnant or breastfeeding women
  • History of previous abdominal surgery
  • History of other previous malignancies
  • Can patients with severe heart, lung, brain diseases tolerate surgical treatment

结局指标

主要结局

Rate of recurrence

时间窗: Within 2 years

次要结局

  • The operation time, complications and hospital stay were recorded(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Qun Zhao

Professor

Hebei Medical University

相似试验